“…As mentioned in the introduction, the nature of neurodegenerative diseases, including Alzheimer’s disease, is largely related to amyloid Aβ42 [ 1 , 2 , 3 , 4 ]. At the same time, research of this amyloid is carried out in several directions, on the one hand, the toxicity of oligomers of this amyloid relative to brain cells is studied [ 5 , 6 , 7 , 8 , 9 , 10 , 11 ], and on the other hand, its structure is explored [ 3 , 4 , 9 ]. One of the main questions: how does the structure of this peptide change when of L-amino acids are replaced by D-analog?…”